Back
Speaker illustration

undefined undefined undefined

Sessions Presentations Events Articles

Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease?

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session type: Great Debates

Access
Like
Thumbnail

Regulatory aspects in clinical trials in heart failure

Event: HFA Clinical Trials in Heart Failure Course 2022

Topic: Heart Failure

Session type: Symposium

Access
Like
Thumbnail

Clinical trial procedures

Event: HFA Clinical Trials in Heart Failure Course 2022

Topic: Heart Failure

Session type: Symposium

Access
Like
Thumbnail

Innovations in pacing 1

Event: ESC Congress 2022

Topic: Antibradycardia Pacing

Session type: Moderated ePosters

Access
Like
Thumbnail

COVID-19 and cardiac arrhythmias

Event: ESC Congress 2022

Topic: Diagnostic Methods

Session type: Moderated ePosters

Access
Like
Thumbnail

Moderated ePosters - Variety of news on device therapy

Event: EHRA 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session type: Moderated Posters

Access
Like
Thumbnail

New insights in ventricular arrhythmias I

Event: EHRA 2021

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Session type: Abstract Sessions

Access
Like
Thumbnail

Device therapy - 60 years later

Event: EHRA 2019

Topic: Antibradycardia Pacing

Session type: Symposium

Access
Like
Thumbnail

Rapid Fire 5: improving the response to cardiac resynchronization therapy: emerging technologies

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session type: Rapid Fire Abstracts

Access
Like
Thumbnail

Moderated ePosters 5: cardiac pacing – insights in old and new modalities

Event: EHRA 2019

Topic: Antibradycardia Pacing

Session type: Moderated Posters

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources